Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation by Thomas H. Dohlman, MD, Rohan Bir Singh, MD, Francisco Amparo, MD, Tatiana Carreno-Galeano, MD, Mohammad Dastjerdi, MD, Giulia Coco, MD, Antonio Di Zazzo, MD, Hasanain Shikari, MD, Ujwala Saboo, MD, Kimberly Sippel, MD, Jessica Ciralsky, MD, Sonia H. Yoo, MD, Matheus Sticca, MD, Tais H. Wakamatsu, MD, Somasheila Murthy, MD, Pedram Hamrah, MD, Ula Jurkunas, MD, Joseph B. Ciolino, MD, Hajirah Saeed, MD, MPH, Jose A.P. Gomes, MD, Victor L. Perez, MD, Jia Yin, MD, PhD, MPH, Reza Dana, MD, MPH

Get full text